EUVIMEDEUVIMED entdecken
Crossref

Synergistic gut microbiome-host lipid axis underlies the antihypertensive effect of Qianyang Yuyin formula

Linjie Wang, Ziwen Xiong, Jingru Chen, Jun Liu, Ming Liu, Xiwu Yan, Zhuyuan Fang

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.157804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Linjie Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drugs, Chinese Herbal, Antihypertensive Agents, Lipid Metabolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prehypertension (Pre-HTN) is highly prevalent and substantially increases the risk of developing hypertension and cardiovascular disease. Gut microbiota (GM) dysbiosis and altered lipid metabolism are increasingly recognized as critical regulators of blood pressure (BP). Traditional Chinese Medicine (TCM) formulas, such as Qianyang Yuyin Granules (QYYY), offer multi-target interventions, yet their preventive mechanisms in Pre-HTN remain unclear. PURPOSE: This study aimed to investigate the antihypertensive effects of QYYY and elucidate its underlying mechanisms in a prehypertensive rat model. METHODS: Prehypertensive spontaneously hypertensive rats (SHRs) were treated with QYYY for four weeks. Multi-omics analyses, including metagenomics, plasma metabolomics, and transcriptomics, were conducted. Causal involvement of GM was tested using antibiotic-induced pseudo-germ-free SHRs with fecal microbiota transplantation (FMT) from QYYY-treated donors, administered alone or in combination with QYYY. Gut barrier integrity, systemic inflammation, and vascular function were evaluated by histology, immunofluorescence, transmission electron microscopy, and ELISA. RESULTS: QYYY significantly lowered SBP and DBP, reversed GM dysbiosis, normalized the Firmicutes/Bacteroidetes ratio, and modulated differential bacteria including Frisingicoccus and Blautia. These microbial shifts correlated with restoration of lysophosphatidylethanolamines (LPEs), inversely associated with BP, revealing a GM-lipid-BP axis. FMT alone was insufficient, whereas the combination of FMT+QYYY produced the strongest antihypertensive effect, restoring intestinal barrier integrity, enhancing ZO-1 expression, and normalizing Ang-II and NO levels. Transcriptomic analyses suggested PPAR and ROS signaling pathways as potential mechanisms mediating the antihypertensive effect of QYYY. CONCLUSION: QYYY prevents BP elevation in Pre-HTN via synergistic microbiota-dependent and independent mechanisms, offering a comprehensive strategy for early hypertension prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDrugs, Chinese HerbalAntihypertensive AgentsLipid MetabolismPrehypertensionAnimalsMaleRatsRats, Inbred SHRBlood PressureFecal Microbiota TransplantationDysbiosisHypertensionDisease Models, Animal

Stichwörter der Autor:innen

Fecal microbiota transplantationGut microbiotaLipid metabolismPrehypertensionQianyang yuyin granules

Substanzen

Drugs, Chinese HerbalAntihypertensive Agents

Autor:innen und Institutionen

  • Department of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
  • Department of Neurology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
  • Institute of Hypertension, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
  • Department of Cardiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China; Institute of Hypertension, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, C…
  • Institute of Hypertension, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China. Electronic address: yxwssg@126.com.
  • Institute of Hypertension, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China. Electronic address: Fangzhuyuan@njucm.edu.cn.

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, L., Xiong, Z., Chen, J., Liu, J., Liu, M., Yan, X., & Fang, Z. (2026). Synergistic gut microbiome-host lipid axis underlies the antihypertensive effect of Qianyang Yuyin formula. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.157804

Vancouver

Wang L, Xiong Z, Chen J, Liu J, Liu M, Yan X, et al. Synergistic gut microbiome-host lipid axis underlies the antihypertensive effect of Qianyang Yuyin formula. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.157804

BibTeX
@article{Wang2026,
  author = {Wang, Linjie and Xiong, Ziwen and Chen, Jingru and Liu, Jun and Liu, Ming and Yan, Xiwu and Fang, Zhuyuan},
  title = {Synergistic gut microbiome-host lipid axis underlies the antihypertensive effect of Qianyang Yuyin formula},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.157804}
}
Kostenlos starten →